Naveen S Basappa

6PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
Patients' lived experiences of fractures during immune checkpoint inhibitor therapy: a qualitative study.

|Sep 24, 2026
Toxicity, Dose Intensity, and Clinical Outcomes with First-Line Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Real-World Study.

|Mar 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis).

Erica Arenovich, Rodney Breau, Ricardo Rendon

|Sep 27, 2024
Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate Cancer.

Gabrielle Robin, Naveen S Basappa, Scott North

|Nov 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System.

Luisa M Cardenas, Sunita Ghosh, Antonio Finelli

|Jul 02, 2021
Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada.

Christopher J D Wallis, Bobby Shayegan, Scott C Morgan

Pageof 1

Frequent Collaborators

2 joint publications

Frederic Pouliot

2 joint publications

Aly-Khan A Lalani

2 joint publications

Michael Kolinsky

1 joint publications

Luisa M Cardenas